Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial

AIMS: There is rising healthcare utilization related to the increasing incidence and prevalence of atrial fibrillation (AF) worldwide. Simplifying therapy and reducing hospital episodes would be a valuable development. The efficacy of a streamlined AF ablation approach was compared to drug therapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanagaratnam, Prapa, McCready, James, Tayebjee, Muzahir, Shepherd, Ewen, Sasikaran, Thiagarajah, Todd, Derick, Johnson, Nicholas, Kyriacou, Andreas, Hayat, Sajad, Hobson, Neil A, Mann, Ian, Balasubramaniam, Richard, Whinnett, Zachary, Earley, Mark, Petkar, Sanjiv, Veasey, Rick, Kirubakaran, Senthil, Coyle, Clare, Kim, Min-Young, Lim, Phang Boon, O’Neill, James, Davies, D Wyn, Peters, Nicholas S, Babalis, Daphne, Linton, Nicholas, Falaschetti, Emanuela, Tanner, Mark, Shah, Jaymin, Poulter, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062288/
https://www.ncbi.nlm.nih.gov/pubmed/36576323
http://dx.doi.org/10.1093/europace/euac253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062288/
https://www.ncbi.nlm.nih.gov/pubmed/36576323
http://dx.doi.org/10.1093/europace/euac253

Ejemplares similares